Clinical Trials Browser

Phase 2 × Pharmacogenomic Testing × 30 days × Clear all

NCT01267955 2026-03-18

Vismodegib in Treating Patients With Advanced Chondrosarcomas

Phase 2 Active not recruiting

45 enrolled 10 charts

Chondrosarcoma, Clear Cell, Chondrosarcoma, Chondrosarcoma, Mesenchymal